Lykke Pedersen

Lykke Pedersen is a Data Science Specialist at Københavns Universitet - University of Copenhagen since November 2025, previously serving as a Product Creator at Novo Nordisk from October 2024 to November 2025. Lykke held multiple roles at Abzu, including Chief Pharma Officer and Head of RNA Therapeutics, from March 2021 to July 2024, and also worked as a Principal Scientist, Senior Scientist, and Scientist at Roche between September 2014 and February 2021. Earlier experience includes a position as a Research Scientist at Santaris Pharma A/S in 2014, a Postdoc at Københavns Universitet from 2012 to 2014, and a Research Assistant at the Niels Bohr Institute from 2008 to 2012, where involvement in biomarker prediction for ovarian cancer was notable. Education includes a PhD in Biophysics from Københavns Universitet, completed in 2012, and a Cand.Scient in Biophysics from the same institution, obtained in 2008.